Correction: Diagnostic Withdrawal Created Weakness in ARIA and an Opportunity for Investors

[ACN Newswire] – In PropThink’s September 26th article on ARIAD Pharmaceuticals (NASDAQ:ARIA), titled Diagnostic Withdrawal Created Weakness in ARIA and an Opportunity for Investors, we wrote:ARIAD initiated … more

View todays social media effects on ARIA

View the latest stocks trending across Twitter. Click to view dashboard